Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Treasury Shares: 2022-2023

Historic Treasury Shares for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to $612,366.

  • Candel Therapeutics' Treasury Shares rose 399.45% to $612,366 in Q3 2023 from the same period last year, while for Sep 2023 it was $612,366, marking a year-over-year increase of 399.45%. This contributed to the annual value of $612,366 for FY2022, which is N/A change from last year.
  • Latest data reveals that Candel Therapeutics reported Treasury Shares of $448,000 as of Q3 2023, which was down 0.00% from $448,000 recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Treasury Shares ranged from a high of $612,366 in Q4 2022 and a low of $122,608 during Q2 2022.
  • Its 2-year average for Treasury Shares is $448,000, with a median of $448,000 in 2023.
  • Data for Candel Therapeutics' Treasury Shares shows a peak YoY spiked of 399.45% (in 2023) over the last 5 years.
  • Candel Therapeutics' Treasury Shares (Quarterly) stood at $448,000 in 2022, then remained steady at $448,000 in 2023.
  • Its Treasury Shares stands at $612,366 for Q3 2023, versus $612,366 for Q2 2023 and $612,366 for Q1 2023.